A citation-based method for searching scientific literature




José C Crispín, Mohamed Oukka, George Bayliss, Robert A Cohen, Christine A Van Beek, Isaac E Stillman, Vasileios C Kyttaris, Yuang-Taung Juang, George C Tsokos. J Immunol 2008
Times Cited: 485




List of shared articles



Times cited

CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis.
Guangyong Sun, Xinyan Zhao, Mingyang Li, Chunpan Zhang, Hua Jin, Changying Li, Liwei Liu, Yaning Wang, Wen Shi, Dan Tian,[...]. Nat Commun 2021
0

Programmed cell death 1 and Helios distinguish TCR-αβ+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells.
Noé Rodríguez-Rodríguez, Sokratis A Apostolidis, Pablo Penaloza-MacMaster, José Manuel Martín Villa, Dan H Barouch, George C Tsokos, José C Crispín. J Immunol 2015
29

Metabolic Factors that Contribute to Lupus Pathogenesis.
Wei Li, Ramya Sivakumar, Anton A Titov, Seung-Chul Choi, Laurence Morel. Crit Rev Immunol 2016
19

Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
Takayuki Katsuyama, George C Tsokos, Vaishali R Moulton. Front Immunol 2018
75

T cells in Systemic Lupus Erythematosus.
Abel Suárez-Fueyo, Sean J Bradley, George C Tsokos. Curr Opin Immunol 2016
66

SLE-Associated Defects Promote Altered T Cell Function.
Jose C Crispin, Christian M Hedrich, Abel Suárez-Fueyo, Denis Comte, George C Tsokos. Crit Rev Immunol 2017
12

Current Insights and Future Prospects for Targeting IL-17 to Treat Patients With Systemic Lupus Erythematosus.
Tomohiro Koga, Kunihiro Ichinose, Atsushi Kawakami, George C Tsokos. Front Immunol 2021
3



A Critical Role for Mucosal-Associated Invariant T Cells as Regulators and Therapeutic Targets in Systemic Lupus Erythematosus.
Goh Murayama, Asako Chiba, Hitoshi Suzuki, Atsushi Nomura, Tomohiro Mizuno, Taiga Kuga, Shinji Nakamura, Hirofumi Amano, Sachiko Hirose, Ken Yamaji,[...]. Front Immunol 2019
12

T Cells in Systemic Lupus Erythematosus.
Jacqueline L Paredes, Ruth Fernandez-Ruiz, Timothy B Niewold. Rheum Dis Clin North Am 2021
0


Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.
Zachary Oaks, Thomas Winans, Nick Huang, Katalin Banki, Andras Perl. Curr Rheumatol Rep 2016
42

Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin.
Andras Perl, Robert Hanczko, Zhi-Wei Lai, Zachary Oaks, Ryan Kelly, Rebecca Borsuk, John M Asara, Paul E Phillips. Metabolomics 2015
66

Immune cell signaling in autoimmune diseases.
George C Tsokos, Noel R Rose. Clin Immunol 2017
6

Novel Treatments in Lupus.
Milena Vukelic, Yi Li, Vasileios C Kyttaris. Front Immunol 2018
17

Metabolic Fitness of T Cells in Autoimmune Disease.
Bowen Wu, Jörg J Goronzy, Cornelia M Weyand. Immunometabolism 2020
5

The role of IL-17 in systemic lupus erythematosus and its potential as a therapeutic target.
Tomohiro Koga, Kunihiro Ichinose, Atsushi Kawakami, George C Tsokos. Expert Rev Clin Immunol 2019
15

T cells and autoimmune kidney disease.
Abel Suárez-Fueyo, Sean J Bradley, David Klatzmann, George C Tsokos. Nat Rev Nephrol 2017
52

T cells and IL-17 in lupus nephritis.
Tomohiro Koga, Kunihiro Ichinose, George C Tsokos. Clin Immunol 2017
58

Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.
Sudhir Kshirsagar, Magdalena Riedl, Heiko Billing, Burkhard Tönshoff, Shanmugapriya Thangavadivel, Christian Steuber, Hagen Staude, Gottfried Wechselberger, Monika Edelbauer. J Immunol 2014
20



Th17 cells in autoimmune diseases.
Lei Han, Jing Yang, Xiuwen Wang, Dan Li, Ling Lv, Bin Li. Front Med 2015
41